New hope for kids with rare, aggressive brain cancers in early drug trial
NCT ID NCT07331064
Summary
This is a first-in-children study to find a safe dose of an experimental oral drug called gallium maltolate for kids whose aggressive brain tumors have returned or not responded to standard treatments. The main goal is to understand the drug's side effects and how the body processes it. Researchers hope the information will help develop better future treatments for these difficult cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE MIDLINE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.